Pre-marketing gets underway for Syngene IPO
Drug research firm Syngene International has started gauging investor interest for its $100m-$150m IPO on the Indian Stock Exchange with the offering expected to hit the market in June.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts